-
Something wrong with this record ?
Sequestration of MBNL1 in tissues of patients with myotonic dystrophy type 2
Z. Lukáš, M. Falk, J. Feit, O. Souček, I. Falková, L. Štefančíková, E. Janoušová, L. Fajkusová, J. Zaorálková, R. Hrabálková,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NS9877
MZ0
CEP Register
Digital library NLK
Full text - Article
Full text - Article
Full text - Article
Full text - Article
Source
- MeSH
- Actins metabolism MeSH
- Analysis of Variance MeSH
- Antigens, CD34 metabolism MeSH
- Endothelium metabolism pathology MeSH
- Microscopy, Confocal MeSH
- Muscle, Skeletal metabolism MeSH
- Skin metabolism pathology MeSH
- Humans MeSH
- Myotonic Disorders diagnosis genetics metabolism pathology MeSH
- Neurofilament Proteins metabolism MeSH
- S100 Proteins metabolism MeSH
- RNA-Binding Proteins genetics metabolism MeSH
- Receptor, Insulin genetics MeSH
- Repetitive Sequences, Nucleic Acid genetics MeSH
- RNA metabolism MeSH
- RNA Splicing genetics MeSH
- Protein Transport physiology MeSH
- Adipocytes metabolism pathology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The pathogenesis of myotonic dystrophy type 2 includes the sequestration of MBNL proteins by expanded CCUG transcripts, which leads to an abnormal splicing of their target pre-mRNAs. We have found CCUG(exp) RNA transcripts of the ZNF9 gene associated with the formation of ribonuclear foci in human skeletal muscle and some non-muscle tissues present in muscle biopsies and skin excisions from myotonic dystrophy type 2 patients. Using RNA-FISH and immunofluorescence-FISH methods in combination with a high-resolution confocal microscopy, we demonstrate a different frequency of nuclei containing the CCUG(exp) foci, a different expression pattern of MBNL1 protein and a different sequestration of MBNL1 by CCUG(exp) repeats in skeletal muscle, vascular smooth muscle and endothelia, Schwann cells, adipocytes, and ectodermal derivatives. The level of CCUG(exp) transcription in epidermal and hair sheath cells is lower compared with that in other tissues examined. We suppose that non-muscle tissues of myotonic dystrophy type 2 patients might be affected by a similar molecular mechanism as the skeletal muscle, as suggested by our observation of an aberrant insulin receptor splicing in myotonic dystrophy type 2 adipocytes.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13000866
- 003
- CZ-PrNML
- 005
- 20140916123040.0
- 007
- ta
- 008
- 130108s2012 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.nmd.2012.03.004 $2 doi
- 035 __
- $a (PubMed)22520280
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Lukáš, Z $u Institute of Pathology, Brno Faculty Hospital, Brno, Czech Republic. zlukas@nbox.cz
- 245 10
- $a Sequestration of MBNL1 in tissues of patients with myotonic dystrophy type 2 / $c Z. Lukáš, M. Falk, J. Feit, O. Souček, I. Falková, L. Štefančíková, E. Janoušová, L. Fajkusová, J. Zaorálková, R. Hrabálková,
- 520 9_
- $a The pathogenesis of myotonic dystrophy type 2 includes the sequestration of MBNL proteins by expanded CCUG transcripts, which leads to an abnormal splicing of their target pre-mRNAs. We have found CCUG(exp) RNA transcripts of the ZNF9 gene associated with the formation of ribonuclear foci in human skeletal muscle and some non-muscle tissues present in muscle biopsies and skin excisions from myotonic dystrophy type 2 patients. Using RNA-FISH and immunofluorescence-FISH methods in combination with a high-resolution confocal microscopy, we demonstrate a different frequency of nuclei containing the CCUG(exp) foci, a different expression pattern of MBNL1 protein and a different sequestration of MBNL1 by CCUG(exp) repeats in skeletal muscle, vascular smooth muscle and endothelia, Schwann cells, adipocytes, and ectodermal derivatives. The level of CCUG(exp) transcription in epidermal and hair sheath cells is lower compared with that in other tissues examined. We suppose that non-muscle tissues of myotonic dystrophy type 2 patients might be affected by a similar molecular mechanism as the skeletal muscle, as suggested by our observation of an aberrant insulin receptor splicing in myotonic dystrophy type 2 adipocytes.
- 650 _2
- $a aktiny $x metabolismus $7 D000199
- 650 _2
- $a tukové buňky $x metabolismus $x patologie $7 D017667
- 650 _2
- $a analýza rozptylu $7 D000704
- 650 _2
- $a antigeny CD34 $x metabolismus $7 D018952
- 650 _2
- $a endotel $x metabolismus $x patologie $7 D004727
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a konfokální mikroskopie $7 D018613
- 650 _2
- $a kosterní svaly $x metabolismus $7 D018482
- 650 _2
- $a myotonické poruchy $x diagnóza $x genetika $x metabolismus $x patologie $7 D020967
- 650 _2
- $a neurofilamentové proteiny $x metabolismus $7 D016900
- 650 _2
- $a transport proteinů $x fyziologie $7 D021381
- 650 _2
- $a RNA $x metabolismus $7 D012313
- 650 _2
- $a sestřih RNA $x genetika $7 D012326
- 650 _2
- $a proteiny vázající RNA $x genetika $x metabolismus $7 D016601
- 650 _2
- $a receptor inzulinu $x genetika $7 D011972
- 650 _2
- $a repetitivní sekvence nukleových kyselin $x genetika $7 D012091
- 650 _2
- $a proteiny S100 $x metabolismus $7 D009418
- 650 _2
- $a kůže $x metabolismus $x patologie $7 D012867
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Falk, M
- 700 1_
- $a Feit, J
- 700 1_
- $a Souček, O
- 700 1_
- $a Falková, I
- 700 1_
- $a Štefančíková, L
- 700 1_
- $a Janoušová, E
- 700 1_
- $a Fajkusová, L
- 700 1_
- $a Zaorálková, J
- 700 1_
- $a Hrabálková, R
- 773 0_
- $w MED00003492 $t Neuromuscular disorders : NMD $x 1873-2364 $g Roč. 22, č. 7 (2012), s. 604-16
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22520280 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130108 $b ABA008
- 991 __
- $a 20140916123449 $b ABA008
- 999 __
- $a ok $b bmc $g 963648 $s 799030
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 22 $c 7 $d 604-16 $i 1873-2364 $m Neuromuscular disorders $n Neuromuscul Disord $x MED00003492
- GRA __
- $a NS9877 $p MZ0
- LZP __
- $a Pubmed-20130108